Rubric Capital Management LP's Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Jul 19, 2022
- Accession no.
- 0001104659-22-080754
- Filed
- Jul 19, 2022, 11:28 AM ET
- Trade date
- Jul 15-18, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $467.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rubric Capital Management LPCIK 0001687509 | 10% Owner |
| Rosen David EfraimCIK 0001898677 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | Common Stock, par value $0.001 per share ("Common Stock") | PPurchaseAcquired | +64,892 | $5.56 | +$360,799.52 | 1,139,265 | Indirect | |
| Jul 18, 2022 | Common Stock | PPurchaseAcquired | +17,688 | $6.03 | +$106,658.64 | 1,156,953 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.